非ステロイド性抗炎症薬（NSAID）の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：D0GIR-01492 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、非ステロイド性抗炎症薬（NSAID）の世界市場を広く調査・分析し、今後の市場展望をまとめております。非ステロイド性抗炎症薬（NSAID）の種類別市場規模（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Aurobindo Pharma、Teva Pharmaceutical、Pfizer、Mylan、Boehringer Ingelheim、Actavis、Lonza Group、Hospira、Dr. Reddy's Laboratories、Wuxi Apptec、Zhejiang NHU ・地域別グローバル市場分析 2015年-2020年 ・非ステロイド性抗炎症薬（NSAID）の北米市場（アメリカ、カナダ、メキシコ） ・非ステロイド性抗炎症薬（NSAID）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非ステロイド性抗炎症薬（NSAID）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非ステロイド性抗炎症薬（NSAID）の南米市場（ブラジル、アルゼンチン） ・非ステロイド性抗炎症薬（NSAID）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論

Market Overview
The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market has been segmented into:
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others

By Application, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) has been segmented into:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market presented in the report. This section sheds light on the sales growth of different regional and country-level Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market.

The report offers in-depth assessment of the growth and other aspects of the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Analysis
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) sales, revenue and market share for each player covered in this report.

The major players covered in Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) are:
Novartis
Aurobindo Pharma
Teva Pharmaceutical
Pfizer
Mylan
Boehringer Ingelheim
Actavis
Lonza Group
Hospira
Dr. Reddy’s Laboratories
Wuxi Apptec
Zhejiang NHU

レポート目次

---

Table of Contents

1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.1 Product Overview and Scope of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
1.2 Classification of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Type
1.2.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2019
1.2.3 Paracetamol
1.2.4 Ibuprofen
1.2.5 Aspirin
1.2.6 Naproxen
1.2.7 Others
1.3 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
1.3.1 Overview: Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Regions
1.4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aurobindo Pharma
2.2.1 Aurobindo Pharma Details
2.2.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aurobindo Pharma SWOT Analysis
2.2.4 Aurobindo Pharma Product and Services
2.2.5 Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva Pharmaceutical SWOT Analysis
2.3.4 Teva Pharmaceutical Product and Services
2.3.5 Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Mylan SWOT Analysis
2.5.4 Mylan Product and Services
2.5.5 Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Actavis
2.7.1 Actavis Details
2.7.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Actavis SWOT Analysis
2.7.4 Actavis Product and Services
2.7.5 Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Lonza Group
2.8.1 Lonza Group Details
2.8.2 Lonza Group Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Lonza Group SWOT Analysis
2.8.4 Lonza Group Product and Services
2.8.5 Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hospira
2.9.1 Hospira Details
2.9.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hospira SWOT Analysis
2.9.4 Hospira Product and Services
2.9.5 Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Dr. Reddy’s Laboratories
2.10.1 Dr. Reddy’s Laboratories Details
2.10.2 Dr. Reddy’s Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Dr. Reddy’s Laboratories SWOT Analysis
2.10.4 Dr. Reddy’s Laboratories Product and Services
2.10.5 Dr. Reddy’s Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wuxi Apptec
2.11.1 Wuxi Apptec Details
2.11.2 Wuxi Apptec Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wuxi Apptec SWOT Analysis
2.11.4 Wuxi Apptec Product and Services
2.11.5 Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Zhejiang NHU
2.12.1 Zhejiang NHU Details
2.12.2 Zhejiang NHU Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Zhejiang NHU SWOT Analysis
2.12.4 Zhejiang NHU Product and Services
2.12.5 Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.2.2 Top 10 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Regions
4.2 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
4.3 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
4.5 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
5 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
5.1 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
5.2 USA Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
5.3 Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
5.4 Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
6 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
6.1 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
6.2 Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
6.3 UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
6.4 France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
6.5 Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
6.6 Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
7.1 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
7.2 China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
7.3 Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
7.4 Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
7.5 India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
8 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries
8.1 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
8.2 Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
8.3 Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Countries
9.1 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
9.3 UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
9.4 Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
9.5 South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Market Share by Type (2015-2020)
10.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Type (2019-2024)
10.3 Paracetamol Revenue Growth Rate (2015-2025)
10.4 Ibuprofen Revenue Growth Rate (2015-2025)
10.5 Aspirin Revenue Growth Rate (2015-2025)
10.6 Naproxen Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment by Application
11.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application (2015-2020)
11.2 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
11.5 Online Pharmacies Revenue Growth (2015-2020)
12 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2021-2025)
12.1 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast (2021-2025)
12.2 Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Forecast by Regions (2021-2025)
12.3 North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
12.4 Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
12.6 South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Novartis Corporate Information, Location and Competitors
Table 6. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 7. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 8. Novartis SWOT Analysis
Table 9. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 10. Novartis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Aurobindo Pharma Corporate Information, Location and Competitors
Table 12. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 13. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2018-2019)
Table 14. Aurobindo Pharma SWOT Analysis
Table 15. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 16. Aurobindo Pharma Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Teva Pharmaceutical Corporate Information, Location and Competitors
Table 18. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 19. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 20. Teva Pharmaceutical SWOT Analysis
Table 21. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 22. Teva Pharmaceutical Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 25. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 28. Pfizer Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Mylan Corporate Information, Location and Competitors
Table 30. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 31. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 32. Mylan SWOT Analysis
Table 33. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 34. Mylan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 36. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 37. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 38. Boehringer Ingelheim SWOT Analysis
Table 39. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 40. Boehringer Ingelheim Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Actavis Corporate Information, Location and Competitors
Table 42. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 43. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 44. Actavis SWOT Analysis
Table 45. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 46. Actavis Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Lonza Group Corporate Information, Location and Competitors
Table 48. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 49. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 50. Lonza Group SWOT Analysis
Table 51. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 52. Lonza Group Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Hospira Corporate Information, Location and Competitors
Table 54. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 55. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 56. Hospira SWOT Analysis
Table 57. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 58. Hospira Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Dr. Reddy's Laboratories Corporate Information, Location and Competitors
Table 60. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 61. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 62. Dr. Reddy's Laboratories SWOT Analysis
Table 63. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 64. Dr. Reddy's Laboratories Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Wuxi Apptec Corporate Information, Location and Competitors
Table 66. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 67. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 68. Wuxi Apptec SWOT Analysis
Table 69. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 70. Wuxi Apptec Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Zhejiang NHU Corporate Information, Location and Competitors
Table 72. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Business
Table 73. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Total Revenue (USD Million) (2017-2018)
Table 74. Zhejiang NHU SWOT Analysis
Table 75. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product and Solutions
Table 76. Zhejiang NHU Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Players (2015-2020)
Table 78. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2015-2020)
Table 79. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions (2015-2020)
Table 81. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
Table 82. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Table 83. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Countries (2015-2020)
Table 86. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Table 89. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) by Type (2015-2020)
Table 90. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2015-2020)
Table 91. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Type (2021-2025)
Table 92. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Application (2015-2020)
Table 93. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2015-2020)
Table 94. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Forecast by Application (2021-2025)
Table 95. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
Figure 2. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type in 2019
Figure 3. Paracetamol Picture
Figure 4. Ibuprofen Picture
Figure 5. Aspirin Picture
Figure 6. Naproxen Picture
Figure 7. Others Picture
Figure 8. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Application in 2019
Figure 9. Hospital Pharmacies Picture
Figure 10. Retail Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2019
Figure 21. Global Top 10 Players Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions (2015-2020)
Figure 25. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Regions in 2018
Figure 26. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 27. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 29. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 31. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Figure 32. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2019
Figure 33. USA Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 34. Canada Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 36. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2019
Figure 38. Germany Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 39. UK Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 40. France Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 41. Russia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 42. Italy Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2019
Figure 45. China Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 46. Japan Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 47. Korea Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 48. India Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 50. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Figure 51. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2019
Figure 52. Brazil Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 57. UAE Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue and Growth Rate (2015-2020)
Figure 60. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type (2015-2020)
Figure 61. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Type in 2019
Figure 62. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Type (2021-2025)
Figure 63. Global Paracetamol Revenue Growth Rate (2015-2020)
Figure 64. Global Ibuprofen Revenue Growth Rate (2015-2020)
Figure 65. Global Aspirin Revenue Growth Rate (2015-2020)
Figure 66. Global Naproxen Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2015-2020)
Figure 69. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application in 2019
Figure 70. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 72. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 73. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
Figure 78. Europe Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
Figure 80. South America Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---